论文部分内容阅读
1雌二醇/醋酸炔诺酮增加心血管等事件的危险诺和诺德(Novo Nordisk)公司对雌二醇/醋酸炔诺酮(estradiol/norethindrone acetate,Activella)说明书中的药品安全内容进行了修改,修改后的说明书于6月30日获美国FDA的批准。新说明书中补充了该药可能使绝经妇女发生心血管事件,乳腺
1 Estradiol / Norethindrone Acetate Increases Risk of Cardiovascular Events Novo Nordisk conducted a safety review of the safety of estradiol / norethindrone acetate (Activella) instructions The revised and revised specifications were approved by the U.S. FDA on June 30. New instructions to supplement the drug may make menopause women cardiovascular events, breast